NEOGENOMICS INC's ticker is and the CUSIP is 64049MAB6. A total of 32 filers reported holding NEOGENOMICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,975,531 | -2.6% | 45,879,000 | -0.5% | 0.17% | +2.4% |
| Q2 2023 | $33,853,507 | -0.6% | 46,132,000 | -0.2% | 0.17% | +0.6% |
| Q1 2023 | $34,060,642 | +15.2% | 46,214,000 | +0.4% | 0.17% | +19.4% |
| Q4 2022 | $29,568,231 | -1.2% | 46,012,000 | -0.6% | 0.14% | +1.5% |
| Q3 2022 | $29,919,000 | +3.5% | 46,292,000 | -0.2% | 0.14% | +9.6% |
| Q2 2022 | $28,908,000 | -6.6% | 46,366,000 | -0.1% | 0.12% | +7.8% |
| Q1 2022 | $30,947,000 | -31.9% | 46,391,000 | -12.8% | 0.12% | -31.8% |
| Q4 2021 | $45,457,000 | -15.8% | 53,220,000 | -0.7% | 0.17% | -28.0% |
| Q3 2021 | $54,018,000 | +17.9% | 53,591,000 | +15.0% | 0.24% | +12.9% |
| Q2 2021 | $45,801,000 | -2.6% | 46,610,000 | +0.2% | 0.21% | -18.7% |
| Q1 2021 | $47,037,000 | – | 46,516,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 62,601,000 | $45,191,662 | 1.43% |
| SILVERBACK ASSET MANAGEMENT LLC | 12,768,000 | $9,114,228 | 1.25% |
| LINDEN ADVISORS LP | 85,576,000 | $61,343,400 | 0.63% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 25,679,000 | $18,537,670 | 0.43% |
| CAMDEN ASSET MANAGEMENT L P /CA | 8,000,000 | $5,695,200 | 0.21% |
| Calamos Advisors LLC | 45,879,000 | $32,975,531 | 0.17% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 7,500,000 | $5,412,612 | 0.12% |
| OAKTREE CAPITAL MANAGEMENT LP | 6,080,000 | $4,389,152 | 0.06% |
| CSS LLC/IL | 805,000 | $577,683 | 0.04% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,708,000 | $5,564,405 | 0.02% |